BHVN

Biohaven Pharmaceutical Holding Company Ltd.

Delisted

BHVN was delisted on the 3rd of October, 2022.

222 hedge funds and large institutions have $5.7B invested in Biohaven Pharmaceutical Holding Company Ltd. in 2021 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 93 increasing their positions, 67 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
222
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
14
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$92.9M
Puts
$79.8M
Net Calls
Net Calls Change

Top Buyers

1 +$128M
2 +$89.3M
3 +$88.2M
4
AG
Artal Group
Luxembourg
+$38.8M
5
Wells Fargo
Wells Fargo
California
+$28.7M

Top Sellers

1 -$149M
2 -$97.1M
3 -$48.5M
4
KCM
Kingdon Capital Management
New York
-$44.6M
5
EP
Eversept Partners
New York
-$16.6M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$6M
77
$5.99M
78
$5.62M
79
$5.28M
80
$5.23M
81
$5.21M
82
$5.17M
83
$5.17M
84
$4.85M
85
$4.85M
86
$4.67M
87
$4.65M
88
$4.62M
89
$4.56M
90
$4.49M
91
$4.45M
92
$4.09M
93
$4.07M
94
$3.95M
95
$3.66M
96
$3.58M
97
$3.5M
98
$3.43M
99
$3.42M
100
$3.34M